stoxline Quote Chart Rank Option Currency Glossary
  
Globus Medical, Inc. (GMED)
51.2  -0.59 (-1.14%)    04-17 16:00
Open: 51.74
High: 52.04
Volume: 1,144,649
  
Pre. Close: 51.79
Low: 51.1
Market Cap: 6,931(M)
Technical analysis
2024-04-17 4:47:02 PM
Short term     
Mid term     
Targets 6-month :  63.06 1-year :  65.4
Resists First :  53.99 Second :  56
Pivot price 52.39
Supports First :  50.75 Second :  42.22
MAs MA(5) :  51.79 MA(20) :  52.23
MA(100) :  52.27 MA(250) :  53.57
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  24.1 D(3) :  28.6
RSI RSI(14): 41.8
52-week High :  62.88 Low :  43.38
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ GMED ] has closed above bottom band by 13.3%. Bollinger Bands are 35.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 52.14 - 52.44 52.44 - 52.76
Low: 50.27 - 50.6 50.6 - 50.95
Close: 50.58 - 51.15 51.15 - 51.77
Company Description

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Headline News

Tue, 16 Apr 2024
Globus Medical Schedules First Quarter Earnings Release and Conference Call - GlobeNewswire

Mon, 15 Apr 2024
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term - Yahoo Finance Australia

Mon, 08 Apr 2024
Globus Medical Breaks Above 200-Day Moving Average - Bullish for GMED - Nasdaq

Mon, 08 Apr 2024
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued - Simply Wall St

Thu, 04 Apr 2024
Globus Medical (GMED) Gains From New Launches Amid Macro Issues - Yahoo Finance

Fri, 29 Mar 2024
Globus Medical (NYSE:GMED) investors are sitting on a loss of 13% if they invested three years ago - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 113 (M)
Shares Float 112 (M)
Held by Insiders 0.7 (%)
Held by Institutions 96.9 (%)
Shares Short 7,760 (K)
Shares Short P.Month 5,730 (K)
Stock Financials
EPS 1.07
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 29.31
Profit Margin 7.8 %
Operating Margin 12.7 %
Return on Assets (ttm) 4.7 %
Return on Equity (ttm) 4.2 %
Qtrly Rev. Growth 124.5 %
Gross Profit (p.s.) 0
Sales Per Share 13.9
EBITDA (p.s.) 3.7
Qtrly Earnings Growth -78.9 %
Operating Cash Flow 244 (M)
Levered Free Cash Flow -347 (M)
Stock Valuations
PE Ratio 47.85
PEG Ratio 1.2
Price to Book value 1.74
Price to Sales 3.68
Price to Cash Flow 23.74
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android